Literature DB >> 20160160

Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.

Judith Hsia1, Rebecca J Rodabough, Joann E Manson, Simin Liu, Matthew S Freiberg, William Graettinger, Milagros C Rosal, Barb Cochrane, Donald Lloyd-Jones, Jennifer G Robinson, Barbara V Howard.   

Abstract

BACKGROUND: The 2007 update to the American Heart Association (AHA) guidelines for cardiovascular disease prevention in women recommend a simplified approach to risk stratification. We assigned Women's Health Initiative participants to risk categories as described in the guideline and evaluated clinical event rates within and between strata. METHODS AND
RESULTS: The Women's Health Initiative enrolled 161 808 women ages 50 to 79 years and followed them prospectively for 7.8 years (mean). Applying the 2007 AHA guideline categories, 11% of women were high risk, 72% at-risk, and 4% at optimal risk; 13% of women did not fall into any category, that is, lacked risk factors but did not adhere to a healthy lifestyle (moderate intensity exercise for 30 minute most days and <7% of calories from saturated fat). Among high risk, at-risk, and optimal risk women, rates of myocardial infarction/coronary death were 12.5%, 3.1%, and 1.1% per 10 years (P for trend <0.0001); the event rate was 1.3% among women who could not be categorized. We observed a graded relationship between risk category and cardiovascular event rates for white, black, Hispanic, and Asian women, although event rates differed among ethnic groups (P for interaction=0.002). The AHA guideline predicted coronary events with accuracy similar to current Framingham risk categories (area under receiver operating characteristic curve for Framingham risk, 0.665; for AHA risk, 0.664; P=0.94) but less well than proposed Framingham 10-year risk categories of <5%, 5% to 20%, and >20% (area under receiver operating characteristic curve for Framingham risk, 0.724; for AHA risk, 0.664; P<0.0001).
CONCLUSIONS: Risk stratification as proposed in the 2007 AHA guideline is simple, accessible to patients and providers, and identifies cardiovascular risk with accuracy similar to that of the current Framingham algorithm. Clinical Trial Registration- clinicaltrials.gov. Identifier: NCT00000611.

Entities:  

Mesh:

Year:  2010        PMID: 20160160      PMCID: PMC2841216          DOI: 10.1161/CIRCOUTCOMES.108.842385

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  27 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  The Women's Health Initiative recruitment methods and results.

Authors:  Jennifer Hays; Julie R Hunt; F Allan Hubbell; Garnet L Anderson; Marian Limacher; Catherine Allen; Jacques E Rossouw
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

3.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative.

Authors:  Judith Hsia; Rebecca Rodabough; Milagros C Rosal; Barbara Cochrane; Barbara V Howard; Linda Snetselaar; William H Frishman; Marcia L Stefanick
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

5.  What do we mean by validating a prognostic model?

Authors:  D G Altman; P Royston
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

6.  Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women.

Authors:  Barbara V Howard; Michael H Criqui; J David Curb; Rebecca Rodabough; Monika M Safford; Nanette Santoro; Alan C Wilson; Judith Wylie-Rosett
Journal:  Metabolism       Date:  2003-03       Impact factor: 8.694

7.  The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.

Authors:  Marcia L Stefanick; Barbara B Cochrane; Judith Hsia; David H Barad; James H Liu; Susan R Johnson
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

8.  The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants.

Authors:  Cheryl Ritenbaugh; Ruth E Patterson; Rowan T Chlebowski; Bette Caan; Lesley Fels-Tinker; Barbara Howard; Judy Ockene
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

9.  Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.

Authors:  Margaret W Cavanaugh-Hussey; Jarett D Berry; Donald M Lloyd-Jones
Journal:  Prev Med       Date:  2008-07-29       Impact factor: 4.018

10.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women.

Authors:  JoAnn E Manson; Philip Greenland; Andrea Z LaCroix; Marcia L Stefanick; Charles P Mouton; Albert Oberman; Michael G Perri; David S Sheps; Mary B Pettinger; David S Siscovick
Journal:  N Engl J Med       Date:  2002-09-05       Impact factor: 91.245

View more
  6 in total

Review 1.  Predictors of cardiovascular risk in women.

Authors:  Tamer Sallam; Karol E Watson
Journal:  Womens Health (Lond)       Date:  2013-09

2.  Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial.

Authors:  Harriet Eldredge-Hindy; Virginia Lockamy; Albert Crawford; Virginia Nettleton; Maria Werner-Wasik; Joshua Siglin; Nicole L Simone; Kulbir Sidhu; Pramila R Anne
Journal:  Pract Radiat Oncol       Date:  2015 Jan-Feb

3.  High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.

Authors:  Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-20       Impact factor: 2.357

4.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

Authors:  Lori Mosca; Emelia J Benjamin; Kathy Berra; Judy L Bezanson; Rowena J Dolor; Donald M Lloyd-Jones; L Kristin Newby; Ileana L Piña; Véronique L Roger; Leslee J Shaw; Dong Zhao; Theresa M Beckie; Cheryl Bushnell; Jeanine D'Armiento; Penny M Kris-Etherton; Jing Fang; Theodore G Ganiats; Antoinette S Gomes; Clarisa R Gracia; Constance K Haan; Elizabeth A Jackson; Debra R Judelson; Ellie Kelepouris; Carl J Lavie; Anne Moore; Nancy A Nussmeier; Elizabeth Ofili; Suzanne Oparil; Pamela Ouyang; Vivian W Pinn; Katherine Sherif; Sidney C Smith; George Sopko; Nisha Chandra-Strobos; Elaine M Urbina; Viola Vaccarino; Nanette K Wenger
Journal:  J Am Coll Cardiol       Date:  2011-03-22       Impact factor: 24.094

5.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

Authors:  Lori Mosca; Emelia J Benjamin; Kathy Berra; Judy L Bezanson; Rowena J Dolor; Donald M Lloyd-Jones; L Kristin Newby; Ileana L Piña; Véronique L Roger; Leslee J Shaw; Dong Zhao; Theresa M Beckie; Cheryl Bushnell; Jeanine D'Armiento; Penny M Kris-Etherton; Jing Fang; Theodore G Ganiats; Antoinette S Gomes; Clarisa R Gracia; Constance K Haan; Elizabeth A Jackson; Debra R Judelson; Ellie Kelepouris; Carl J Lavie; Anne Moore; Nancy A Nussmeier; Elizabeth Ofili; Suzanne Oparil; Pamela Ouyang; Vivian W Pinn; Katherine Sherif; Sidney C Smith; George Sopko; Nisha Chandra-Strobos; Elaine M Urbina; Viola Vaccarino; Nanette K Wenger
Journal:  Circulation       Date:  2011-02-14       Impact factor: 29.690

6.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.